Gene · 3159
Papers3,810
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,810
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Secretome Analysis: Reading Cellular Sign Language to Understand Intercellular Communication. | Mol Cell Proteomics | 2024 | 38081362 | PubTator, text mining | PubMed |
| Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response. | Noncoding RNA Res | 2024 | 38075202 | PubTator, text mining | PubMed |
| The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation. | Cell Mol Immunol | 2024 | 38062129 | PubTator, text mining | PubMed |
| Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations. | Transl Oncol | 2024 | 38042137 | PubTator, text mining | PubMed |
| Biochemical and cellular insights into the Baz2B protein, a non-catalytic subunit of the chromatin remodeling complex. | Nucleic Acids Res | 2024 | 38000389 | PubTator, text mining | PubMed |
| GPR37-centered ceRNA network contributes to metastatic potential in lung adenocarcinoma: Evidence from high-throughput sequencing. | Transl Oncol | 2024 | 37979558 | PubTator, text mining | PubMed |
| Low expression of ZFP36L1 in osteosarcoma promotes lung metastasis by inhibiting the SDC4-TGF-β signaling feedback loop. | Oncogene | 2024 | 37935976 | PubTator, text mining | PubMed |
| Prognostic and clinical value of circPRKCI expression in diverse human cancers. | Chin Med J (Engl) | 2024 | 37718264 | PubTator, text mining | PubMed |
| Circ_UBAP2 exacerbates proliferation and metastasis of OS via targeting miR-665/miR-370-3p/HMGA1 axis. | Environ Toxicol | 2024 | 37676907 | PubTator, text mining | PubMed |
| Lin28 as a therapeutic target for central nervous system regeneration and repair. | Neural Regen Res | 2024 | 37488899 | PubTator, text mining | PubMed |
| Uterine leiomyoma with RAD51B::NUDT3 fusion: a report of 2 cases. | Virchows Arch | 2024 | 37466765 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals a cancer-associated fibroblast marker gene signature in hepatocellular carcinoma that predicts prognosis. | ILIVER | 2023 | 40636406 | PubTator, text mining | PubMed |
| LINC01614 Promotes Colorectal Cancer Cell Growth and Migration by Regulating miR-217-5p/HMGA1 Axis. | Anal Cell Pathol (Amst) | 2023 | 39282156 | PubTator, text mining | PubMed |
| HMGA2 promotes nasopharyngeal carcinoma progression and is associated with tumor resistance and poor prognosis. | Front Oncol | 2023 | 38304037 | PubTator, text mining | PubMed |
| Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling. | Front Pharmacol | 2023 | 38269272 | PubTator, text mining | PubMed |
| Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide. | Front Genet | 2023 | 38259614 | PubTator, text mining | PubMed |
| Editorial: The role of tumor microenvironment in the development, treatment and prognosis of hepatocellular carcinoma. | Front Pharmacol | 2023 | 38239197 | PubTator, text mining | PubMed |
| Identification of potential crosstalk genes and mechanisms between periodontitis and diabetic nephropathy through bioinformatic analysis. | Medicine (Baltimore) | 2023 | 38206700 | PubTator, text mining | PubMed |
| Statins-From Fungi to Pharmacy. | Int J Mol Sci | 2023 | 38203637 | PubTator, text mining | PubMed |
| The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors. | Molecules | 2023 | 38202657 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3159/papers?page=13